Document Classification

Section Type: RESULTS

Text: A significant improvement in post-prandial plasma glucose (PPPG) levels (9. 1 + / -1. 7 and 8. 4 + / -1. 3 mmol/L, p = 0. 002) and HbA (1c) (7. 08 + / -0. 48 and 6. 86 + / -0. 45 %, p = 0. 001) were observed in the pioglitazone treated group, but not in the placebo treated group (8. 3 + / -1. 8 and 7. 8 + / -1. 8 mmol/L, p = 0. 06 and HbA (1c) 7. 3 + / -0. 37 and 7. 24 + / -0. 33 %, p = 0. 74, respectively).